The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sloan Sheldon since 2026.
This trader's CIK number is 2038798.
At the time of last reporting, Sloan Sheldon was the Chief Medical Officer of Spyre Therapeutics, Inc.. (stock ticker symbol SYRE).
Also see all insider trading activities at Spyre Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | SYRE | 0 | $0 | 7,958 | $397,900 | 7,958 | $172,370 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-01 | SYRE | Option Ex | 7,958 | 21.66 | 172,370 |
| 2026-04-01 | SYRE | Sale | 7,958 | 50.00 | 397,900 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sloan Sheldon (Chief Medical Officer of Spyre Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.